Skip to content

GENITAL AROUSAL AND PELVIC FLOOR MUSCLE ACTIVITY IN RESPONSE TO EROTIC AND THREATENING STIMULI IN WOMEN WITH DYSPAREUNIA AND SEXUALLY FUNCTIONAL CONTROLS

GENITAL AROUSAL AND PELVIC FLOOR MUSCLE ACTIVITY IN RESPONSE TO EROTIC AND THREATENING STIMULI IN WOMEN WITH DYSPAREUNIA AND SEXUALLY FUNCTIONAL CONTROLS - GENITAL AROUSAL AND PELVIC FLOOR MUSCLE ACTIVITY IN WOMEN WITH DYSPAREUNIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57749
Enrollment
128
Registered
2012-05-01
Start date
2012-06-28
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painful intercourse sexual pain complaint

Interventions

Women will be exposed to an emotion induction (sexual arousal and anxiety) using erotic film and threathening film excerpts. Also, fear of pain will be induced by exposing participants to the sugges

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women with dyspareunia will be selected based on the DSM-IV-TR (APA, 2000) diagnosis of dyspareunia. Control subjects will be included if they have had no sexual complaints for at least one year, and were sexually active including intercourse. Inclusion criteria for both groups will be age >= 18

Exclusion criteria

Exclusion criteria: Women will be excluded if any of the following applies: homosexual orientation (because of the heterosexual erotic film stimuli); pregnancy or lactation; a diagnosis of affective, psychotic or substance related disorder according to DSM-IV-TR; having undergone a radical hysterectomy or prolapse surgery; using medication that may affect sexual response (to determine possible sexual side-effects the *Farmacotherapeutisch kompas* will be used); disorders of the genitals or pelvis that may influence sexual arousal or pelvic floor responses, or the measurement of these responses; other medical disorders that may influence the sexual arousal or pelvic floor responses, or the measurement of these responses.

Design outcomes

Primary

MeasureTime frame
- genitale sexual arousal measured by photoplethysmography - pelvic floor activity measured by surface EMG at the pelvic floor muscles

Secondary

MeasureTime frame
- muscle activity in the trapezius - subjective sexual arousal and affect

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)